|
Report ID
|
58113 |
|
Drug Identification Number
|
02018144 |
|
Brand name
|
CYCLOMEN |
|
Common or Proper name
|
Cyclomen 50mg |
|
Company Name
|
SANOFI-AVENTIS CANADA INC |
|
Market Status
|
CANCELLED POST MARKET |
|
Active Ingredient(s)
|
DANAZOL |
|
Strength(s)
|
50MG |
|
Dosage form(s)
|
CAPSULE |
|
Route of administration
|
ORAL |
|
Packaging size
|
100 |
|
Anatomical Therapeutical Chemical (ATC) code
|
G03XA |
|
Anatomical Therapeutical Chemical (ATC) description
|
OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
|
Reason for shortage
|
Other (Please describe in comments) |
|
Anticipated start date
|
2018-09-28 |
|
Actual start date
|
|
|
Estimated end date
|
2020-01-31 |
|
Actual end date
|
2020-01-06 |
|
Shortage status
|
Resolved |
|
Updated date
|
2020-01-07 |
|
Company comments
|
Delay in manufacturing. |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
email: [email protected]
Telephone: 1-800-265-7927 |
